Delivery Order SPE2DB24D9313-SPE2DB25FYBHP
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,115.65 by the Defense Logistics Agency on July 23, 2025, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of July 24, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on July 31, 2025, by the Defense Logistics Agency for the supply of Jakafi 10 mg tablets (60-count unit). This firm fixed-price delivery order, valued at $24,231.30, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The contract includes no set-aside designation, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12.0K on July 22, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for logistics and supply chain management. The award carries an ultimate completion date of July 23, 2025, and...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a $12,044.38 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on September 29, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This delivery order, which carries an ultimate completion date of September 30, 2025, was issued without set-aside designation, allowing the vendor to compete directly in the federal procurement market. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Jakafi 10 mg tablets (60-count units) with a ceiling value of $24,231.30. The contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. This award is issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 27, 2025, for the supply of Jakafi 15 mg tablets (60-count units). This firm fixed-price delivery order, valued at $36,115.27, represents a single issuance under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of $500...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total contract value of $499,999,999 through...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,231.30 by the Defense Logistics Agency on August 11, 2025, for the supply of Jakafi 10 mg tablets (60-count units). The contract carries no set-aside designation and is scheduled for completion by August 12, 2025, with performance to occur at the contractor's Park Ridge, Illinois facility. This delivery order is issued...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,089.78 for the supply of Jakafi 20mg tablets (60-count) by the Medical Supply Chain, a Defense agency component. The contract, issued on September 19, 2025, with completion targeted for October 10, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on May 8, 2025, by the Defense Logistics Agency for Jakafi 10 mg tablets (60-count units). The contract is valued at $12,115.65 and represents a firm fixed-price delivery order with an ultimate completion date of May 9, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its...
- SPE2DB24D9313Indefinite Delivery Contract
- SPE2DB24D9313-SPE2DB25FYBHPDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 22, 2025, for the supply of Jakafi 10 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of approximately $12.1K. The award represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, a $500M vehicle valid through November 2026 that enables the agency to procure a broad range of pharmaceutical products and medical consumables for Department of Defense healthcare facilities. No set-aside designation was applied to this particular delivery order, reflecting the company's competitive positioning in federal pharmaceutical procurement markets. The contract specifies Park Ridge, Illinois as the place of performance and an ultimate completion date of September 23, 2025. Jakafi (ruxolitinib) is a prescription medication used primarily in the treatment of myelofibrosis and other blood disorders, reflecting the DLA's need to maintain pharmaceutical inventory for military medical treatment facilities. DMS Pharmaceutical Group's role as a key supplier within the federal pharmaceutical supply chain is demonstrated through its consistent award of delivery orders covering diverse product categories ranging from oncology treatments to specialty medications and biologics, positioning the company as an essential distributor supporting Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 9/22/25 |